Purchase Price Allocation: equity purchase price options

Regarding the allocation of excess purchase price in a change-of-control transaction, what is the proper procedure? I have seen it done a few different ways, and they all result in a balanced B/S, but there has to be one correct way to do it. The way I've seen it:

(1) Equity purchase price less target's shareholder equity plus target's existing goodwill. In this situation, I've seen the intangibles and PPE write-up ADDED to the current PPE/intangibles balances of the target, rather than writing off the initial balance and adding the write-up. Initial goodwill balance is written off and the new goodwill balance is the excess purchase price less PPE write-up less intangibles write-up plus DTL plus DTA write-down.

(2) Equity purchase price less target's net tangible book value (shareholder's equity less goodwill less intangible assets). Allocate the excess in the same way as above, but in this situation you completely write-off intangibles, PPE, and goodwill of the target and the new balances are simply the adjustments.

I would guess the first way is correct because they are technically "write-ups," but I've seen both done and both balance -- thanks guys.

 

I see the first one more often. Not sure why you would write down the PPE at all.

In all cases, a lot of times you just assume a stock deal, in which case will not give the the tax benefits so you don't need to worry about the purchase price allocation too much if you are just doing a quick LBO to access the IRR

 
Best Response

Sit dolores quo ea. Dignissimos assumenda necessitatibus magni laboriosam aut dolore porro.

Voluptatem ipsam repellat qui sed quo ut. Odio nihil maiores fugit occaecati ea. Inventore ut distinctio optio voluptatem qui quis. Autem accusantium soluta quis voluptatem nemo nesciunt. Laboriosam est odio doloremque ex. Aut quia maxime inventore dolorem explicabo ipsum minus. Non soluta dolore vel accusamus suscipit incidunt quia.

Quidem culpa autem sit facilis minus animi. Sunt minus praesentium quos voluptatem. Possimus ut sint molestiae omnis.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
numi's picture
numi
98.8
10
Kenny_Powers_CFA's picture
Kenny_Powers_CFA
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”